EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The evaluation of effectiveness of IL-17 and IL-23 inhibitors on nail and enthesis involvement in early psoriatic arthritis patients by high-frequency ultrasonography: a single-centre prospective proof-of-concept study

Piero Ruscitti, Camilla Gianneramo, Pierpaolo Palumbo, Manfredo Bruni, Martina Gentile, Sabrina Lanzi, Emanuele Vagnozzi, Alessia Loda, Lina Maria Magnanimi, Maria Concetta Fargnoli, Antonio Barile, Paola Cipriani und 1 weitere

La radiologia medica · 2025

DOI: 10.1007/s11547-025-02086-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift La radiologia medica, 2025. Verfasst von Piero Ruscitti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Delta 6 Building, Via Dell' Ospedale, PO Box 67100, L'Aquila, I…. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Interleukin-23, Interleukin-17, Nails. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi dell’Aquila.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the effectiveness of IL-17 and IL-23 inhibitors in psoriatic nail and enthesis involvement by ultrasonography with the use of high-frequency probes (HFUS). To correlate the obtained HFUS findings with disease activity of patients with psoriatic arthritis (PsA). Material and Methods Consecutive early naïve patients with PsA underwent HFUS on nails and entheses before and after 24 weeks of treatment with IL-17 or IL-23 inhibitor. The Brown University Nail Enthesis Scale (BUNES), considering morphometry and Power Doppler (PD), and the Madrid Sonography Enthesitis Index (MASEI) score were used to evaluate these features. HFUS findings were correlated with the extension of the disease on skin by Psoriasis Area and Severity Index (PASI) and joints by Disease Activity Index for Psoriatic Arthritis (DAPSA).

Results

Twenty early naïve patients with PsA were treated for 24 weeks with an IL-17 or IL-23 inhibitor. A significant reduction of BUNES PD was observed considering the whole cohort of patients receiving these drugs ( p = 0.044), whereas, despite a trend, no significant difference was reported comparing BUNES morphometry. The BUNES PD correlated with PASI ( r = 0.466, p = 0.030) and with DAPSA ( r = 0.444, p = 0.032), whereas BUNES morphometry did not. A significant reduction of MASEI was observed considering the whole assessed cohort of patients treated with these drugs ( p = 0.045). The MASEI correlated with both PASI ( r = 0.429, p = 0.037) and DAPSA ( r = 0.499, p = 0.017).

Conclusions

This proof-of-concept study demonstrated that the assessment by HFUS may provide additional accurate information about the effectiveness of IL-17 and IL-23 inhibitors in psoriatic nail and enthesis involvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, PsoriaticInterleukin-23Interleukin-17NailsNail DiseasesHumansProspective StudiesMaleFemaleMiddle AgedAdultProof of Concept StudyUltrasonographyTreatment OutcomeSeverity of Illness Index

Stichwörter der Autor:innen

PsoriasisPsoriatic arthritisTherapyUltrasonography with high-frequency probes

Substanzen

Interleukin-23Interleukin-17

Autor:innen und Institutionen

  • Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Delta 6 Building, Via Dell' Ospedale, PO Box 67100, L'Aquila, Italy. piero.ruscitti@univaq.it.
  • Department of Emergency and Interventional Radiology, San Salvatore Hospital, Abruzzo Health Unit 1, L'Aquila, Italy.
  • Department of Diagnostic Imaging, Area of Cardiovascular and Interventional Imaging, San Salvatore Hospital, Abruzzo Health Unit 1, L'Aquila, Italy.
  • Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Delta 6 Building, Via Dell' Ospedale, PO Box 67100, L'Aquila, Italy.
  • San Gallicano Dermatological Institute, IRCCS, Rome, Italy.

Förderung

  • Università degli Studi dell’Aquila

Zitieren

APA

Ruscitti, P., Gianneramo, C., Palumbo, P., Bruni, M., Gentile, M., Lanzi, S., Vagnozzi, E., Loda, A., Magnanimi, L. M., Fargnoli, M. C., Barile, A., Cipriani, P., & Esposito, M. (2025). The evaluation of effectiveness of IL-17 and IL-23 inhibitors on nail and enthesis involvement in early psoriatic arthritis patients by high-frequency ultrasonography: a single-centre prospective proof-of-concept study. La radiologia medica. https://doi.org/10.1007/s11547-025-02086-9

Vancouver

Ruscitti P, Gianneramo C, Palumbo P, Bruni M, Gentile M, Lanzi S, et al. The evaluation of effectiveness of IL-17 and IL-23 inhibitors on nail and enthesis involvement in early psoriatic arthritis patients by high-frequency ultrasonography: a single-centre prospective proof-of-concept study. La radiologia medica. 2025. doi:10.1007/s11547-025-02086-9

BibTeX
@article{Ruscitti2025,
  author = {Ruscitti, Piero and Gianneramo, Camilla and Palumbo, Pierpaolo and Bruni, Manfredo and Gentile, Martina and Lanzi, Sabrina and Vagnozzi, Emanuele and Loda, Alessia and Magnanimi, Lina Maria and Fargnoli, Maria Concetta and Barile, Antonio and Cipriani, Paola and Esposito, Maria},
  title = {The evaluation of effectiveness of IL-17 and IL-23 inhibitors on nail and enthesis involvement in early psoriatic arthritis patients by high-frequency ultrasonography: a single-centre prospective proof-of-concept study},
  journal = {La radiologia medica},
  year = {2025},
  doi = {10.1007/s11547-025-02086-9}
}
Kostenlos starten →